Counterfeit Drugs Health, Social & Economic Impact
Mohammad has a unique blend of both technical and business experience and qualifications. After graduating in pharmaceutical science, he has held posts in the fields of R&D and production of pharmaceutical dosage forms and as a toll manufacturing coordinator then, after completing postgraduate certificate in management from AUC, he has senior management roles in business development in pharmaceutical industry mainly in the area of planning, supply chain, process management & improvement and business excellence models and he leads teams for different QMS inspections as GMP & ISO 9001 inspections.
During his career in business development in the pharmaceutical industry including registration of new pharmaceutical products for local & export markets which allowed him to deal with different regulatory authorities with different regulatory systems including CTD&eCTD. Also, he took the responsibility of establishing & structuring the supply chain department within the company to cover production planning, inventory control, distribution inside & outside Egypt for pharmaceutical companies. During his career life, he conducted a lot of training sessions as an internal training instructor for his team & as QMS consultant, the regional trainer in REYADA PRO Consulting Co. and as a speaker in Compliance online & GRC.
Counterfeit drugs pose a public health hazard, waste consumer income, and reduce the incentive to engage in research and development and innovation. Stronger state licensure supervision of drug suppliers would be helpful. Technological approaches, such as the Radio Frequency Identification devices, should also be considered. Finally, counterfeit drugs may raise concerns among consumers about the safety and reduce patient medication adherence.
Counterfeit drugs are not necessarily of the quality they purport to be and may be mislabeled with respect to identity and/or source. They can be imported, smuggled or manufactured locally by large consortia in large factories and establishments equipped with the most modem equipment, or by small-time operators in smaller, often poorly equipped facilities.
One in 10 drugs sold in developing countries is fake or substandard, leading to tens of thousands of deaths, many of them of African children given ineffective treatments for pneumonia and malaria, health officials said on Tuesday. In a major review of the problem, the World Health Organization (WHO) said that bogus drugs are growing threats as increased pharmaceutical trade, including Internet sales; open the door to sometimes toxic products.
Trade in counterfeit drugs appears to be widespread internationally and affects both developing and developed countries. The spread of counterfeit drugs is generally more pronounced in those countries where the manufacture, importation, distribution, supply, and sale of drugs are less regulated and enforcement may be weak. Current information indicates that drug counterfeiting is becoming more and more sophisticated, and thus the responsible authorities in the Member States are advised to keep this issue under constant review.
- Definition of counterfeit medicines
- Impact on public health
- Impact on economics
- Factors facilitating counterfeiting
- Measures to be taken for facing counterfeiting
Course Level - Basic to intermediate
Who Should Attend
- Quality assurance in the pharma industry
- Anyone interested in public health issues
Why Should Attend
- To know the great risks of drug counterfeiting
- To know the impact of drug counterfeiting on both public health
- To impact of drug counterfeiting on macro & microeconomics
- To know how to face this problem